Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Tomotaka Dohi"'
Autor:
Hiroki Nishiyama, Takehiro Funamizu, Hiroshi Iwata, Hirohisa Endo, Yuichi Chikata, Shinichiro Doi, Hideki Wada, Ryo Naito, Manabu Ogita, Yoshiteru Kato, Iwao Okai, Tomotaka Dohi, Takatoshi Kasai, Kikuo Isoda, Shinya Okazaki, Katsumi Miyauchi, Tohru Minamino
Publikováno v:
International journal of cancer. 151(9)
Previous studies showed that elevated apolipoprotein A1 (ApoA1) and high-density lipoprotein cholesterol (HDL-C) predicted reduced risk of cardiovascular-related (CV) mortality in patients following percutaneous coronary intervention (PCI). Neverthel
Autor:
Kazunori Shimada, Tomotaka Dohi, Manabu Ogita, Shinya Okazaki, Hiroyuki Daida, Katsumi Miyauchi, Hideaki Bujo, Norihito Takahashi, Takatoshi Kasai, Satoru Suwa, Hideki Wada
Publikováno v:
International Heart Journal. 61:470-475
Cardiovascular events still occur despite statin-based lipid-lowering therapy in patients with coronary artery disease (CAD). LR11, a member of the low-density lipoprotein receptor family, is a novel marker for the proliferation of intimal smooth mus
Autor:
Hirohisa Endo, Hiroyuki Daida, Takatoshi Kasai, Hideki Wada, Katsumi Miyauchi, Hirokazu Konishi, Tomotaka Dohi, Shinya Okazaki, Manabu Ogita, Ryo Naito, Satoru Suwa, Shuta Tsuboi, Shinichiro Doi, Jun Shitara, Kikuo Isoda
Publikováno v:
Journal of Cardiology. 73:45-50
Introduction C-reactive protein (CRP) is an established marker for vascular inflammation and predictor of adverse cardiovascular events, but the prognostic value of preprocedural CRP in coronary artery disease (CAD) patients who have undergone percut
Autor:
Shinichiro Doi, Jun Shitara, Hirohisa Endo, Yuya Nishida, Takehiro Funamizu, Manabu Ogita, Hideki Wada, Takatoshi Kasai, Shinya Okazaki, Hiroshi Iwata, Hiroyuki Daida, Tomotaka Dohi, Katsutoshi Miyosawa, Yuichi Chikata, Kikuo Isoda, Katsumi Miyauchi, Ryo Naito
Publikováno v:
Cardiovascular Diabetology
Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-12 (2020)
Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-12 (2020)
Background In the secondary prevention of cardiovascular (CV) disease in patients with diabetes, an optimal level of HbA1c, the most widely-used glycemic control indicator, for favorable clinical consequences still remains to be established. This stu
Autor:
Hiroshi Iwata, Hideki Wada, Norihito Takahashi, Yoshiteru Kato, Shinya Okazaki, Kikuo Isoda, Hirohisa Endo, Shinichiro Doi, Manabu Ogita, Kazunori Shimada, Katsumi Miyauchi, Tomotaka Dohi, Takehiro Funamizu, Iwao Okai
Publikováno v:
Journal of cardiology. 76(1)
Background Serum levels of lipoprotein (a) [Lp(a)] have been reported as a residual risk marker for adverse events in patients with coronary artery disease (CAD). However, the prognostic impact of Lp(a) on long-term clinical outcomes among diabetic p
Autor:
Kikuo Isoda, Manabu Ogita, Tomotaka Dohi, Shinichiro Doi, Jun Shitara, Takatoshi Kasai, Satoru Suwa, Hideki Wada, Katsumi Miyauchi, Hirohisa Endo, Hiroyuki Daida, Shinya Okazaki, Takashi Shimizu
Publikováno v:
International heart journal. 60(5)
Although high-sensitivity C-reactive protein (hs-CRP) has been used to predict the risk of adverse cardiac events in patients with coronary artery disease (CAD) after percutaneous coronary interventions (PCIs), little is known about the association b
Autor:
Shigemi Hosogaya, Junken Aoki, Noboru Sakai, Minoru Tozuka, Tatsuya Kishimoto, Yukio Ozaki, Shigeo Okubo, Tomotaka Dohi, Hiroyuki Daida, Hitoshi Ikeda, Takahiro Nojiri, Makoto Kurano, Katsumi Miyauchi, Ryunosuke Ohkawa, Koji Igarashi, Yutaka Yatomi
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-12 (2018)
Scientific Reports
Scientific Reports
Blood choline has been proposed as a predictor of acute coronary syndrome (ACS), however different testing procedures might affect the choline concentration because the lysophospholipase D activity of autotaxin (ATX) can convert lysophosphatidylcholi
Autor:
Hiroyuki Daida, Hirohisa Endo, Hakuoh Konishi, Ahmed Hassan, Ryo Naito, Shinya Okazaki, Shuta Tsuboi, Manabu Ogita, Tomotaka Dohi, Takatoshi Kasai, Katsumi Miyauchi, Shinichiro Doi, Jun Shitara, Kikuo Isoda, Hideki Wada, Satoru Suwa
Publikováno v:
Nutrition, Metabolism and Cardiovascular Diseases. 28:285-290
Background and aims Low serum albumin level is reportedly associated with worse clinical outcomes in patients with chronic kidney disease (CKD). However, associations between decreased serum albumin level and outcomes in non-CKD patients with coronar
Autor:
Shinya Okazaki, Shuta Tsuboi, Satoru Suwa, Kikuo Isoda, Tomotaka Dohi, Taketo Sonoda, Takatoshi Kasai, Katsumi Miyauchi, Hirokazu Konishi, Hiroyuki Daida, Ryo Naito, Hideki Wada, Manabu Ogita
Publikováno v:
Journal of Atherosclerosis and Thrombosis
Aims: Cardiovascular risk persists despite intensive lipid lowering therapy using statins. Serum levels of lipoprotein (a) [Lp(a)] can be a residual cardiovascular risk for adverse events. Aim of the present study was to evaluate the impact of Lp(a)
Autor:
Iwao Okai, Kikuo Isoda, Hiroshi Iwata, Tomotaka Dohi, Hideki Wada, Norihito Takahashi, Katsumi Miyauchi, Hirohisa Endo, Manabu Ogita, Satoru Suwa, Shinya Okazaki, Hiroyuki Daida, Kazunori Shimada, Yoshiteru Kato
Publikováno v:
Cardiovascular Diabetology
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-9 (2019)
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-9 (2019)
Background A low 1,5-anhydro-d-glucitol (AG) blood level is considered a clinical marker of postprandial hyperglycemia. Previous studies reported that 1,5-AG levels were associated with vascular endothelial dysfunction and coronary artery disease (CA